Basic Information
Curamir Therapeutics is dedicated to developing cancer therapies based on micro RNA (miRNA). Leveraging its proprietary miRNA engineering platform and insights into cancer biology, the company develops innovative treatments aimed at addressing unmet needs to overcome resistance and toxicity associated with current oncology therapies.
Curamir Therapeutics, Inc.
Massachusetts,United States of America
less than 15 people
March 25, 2019
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios